GL1X · GenesisL1 explorer

Research workbench

Anthranilate phosphoribosyltransferase (trpd) from mycobacterium tuberculosis (complex with inhibitor ACS179)

Analyse Anthranilate phosphoribosyltransferase (trpd) from mycobacterium tuberculosis… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3R6C
Type
protein
Length
692 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Anthranilate phosphoribosyltransferase
EC
2.4.2.18
UniProt
P66992
Ligands
17N, PRP, MG
Pockets
6 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 52% helix, 12% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BAnthranilate phosphoribosyltransferase (EC 2.4.2.18)protein34652% helix, 12% strandP66992

Ligands and binding sites

  • 17N · 8-methoxyphenanthro[3,4-d][1,3]dioxole-5,6-dicarboxylic acid · ligand · 3 copies · chains A, B
  • PRP · 1-O-pyrophosphono-5-O-phosphono-alpha-D-ribofuranose · ligand · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 4 copies · chains A, B
  • GOL · Glycerol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14360.780.8752PRP, MG
23910.770.8751PRP, MG, 17N
31010.400.772517N
4660.370.791817N
5700.330.7515empty

Interfaces

1 interface between chains.

  • A–B · 880 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 3R6C · Anthranilate phosphoribosyltransferase (trpD) from Mycobacterium tuberculosis (complex… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.